Advanced BioHealing
Advanced BioHealing (ABH) was founded in 2003 to develop and commercialize a next-generation bioengineered tissue product. In late 2005, when U.K. based Smith & Nephew announced the sale of assets related to their bioengineered tissue business, the opportunity to purchase these products (Dermagraft & TransCyte) seemed to fit perfectly with the ABH strategy. Both products were already approved for sale in the U.S. (and a number of other countries) thus providing ABH an “instant” commercial opportunity. After evaluating the commercial opportunity and tasks for re-starting manufacturing it was clear there were many reasons to purchase the global rights to these outstanding products and the decision was taken to proceed. The deal was finalized in May, 2006.
www.advancedbiohealing.com
ReVision Optics
ReVision Optics, Inc. develops, manufactures and markets implantable products that correct and maintain vision. Its lenses, the PRESBYLENS™ Corneal Inlay (CI) is a unique, patented refractive surgery solution that is designed to correct vision lost by the natural aging process called presbyopia. The PRESBYLENS™ CI is designed to be removable, adjustable and improve near vision with little or no compromise at distance. The potential result is a significantly less risky and better-suited treatment of presbyopia than subtractive technologies such as LASIK.
www.revisionoptics.comMeet Specializing Partners
Brent Ahrens
Stephen Bloch
Peter Farina
Wende Hutton
Seth Rudnick
Tim Shannon
Santhosh Vadivelu
News
Downloads
Canaan Brochure [pdf, 1.2MB]
Healthcare Factsheet [pdf, 1.16MB]
